Delivery Order SPE2DB20D1100-SPE2DB25FE0HE
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,266.02 for 100 tablets of Adderall 15 mg, with a completion date of September 5, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a single delivery order executed under AmerisourceBergen's larger pharmaceutical supply framework with the...
- The Defense Logistics Agency awarded a $3,798.06 delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 15 mg tablets (100 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This is a firm fixed-price, non-set-aside contract awarded competitively to the prime contractor. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 15 mg tablets (100-count units) under a firm fixed-price contract valued at $2,739.72. The order was competitively awarded with no set-aside designation and carries an ultimate completion date of August 29, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Adderall 15 mg tablets (100 count) with a ceiling value of $5,233.57. This firm fixed-price delivery order, with an ultimate completion date of September 11, 2025, represents a single pharmaceutical supply transaction under AmerisourceBergen's existing contract vehicle with DLA. The order will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. No...
- The Defense Logistics Agency awarded a delivery order valued at $5,366.61 to AmerisourceBergen Drug Corp for 100 tablets of Adderall 15 mg, with an ultimate completion date of August 15, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its primary headquarters. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Adderall 10 mg tablets in quantities of 100, with a ceiling value of $3,012.75 and a firm fixed price structure. This is a non-set-aside competitive award with an ultimate completion date of September 9, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, which serves as the company's headquarters and a...
- The Defense Logistics Agency awarded a delivery order valued at $1,528.86 to AmerisourceBergen Drug Corp for the supply of Adderall 20 mg tablets (100 count units) with a completion deadline of June 2, 2025. This is a competitively awarded, firm fixed price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly for...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $14,266.54 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) under a firm fixed price contract. The order was competitively awarded without set-aside designation and carries an ultimate completion date of July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor supporting federal medical procurement needs across...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100 count) with a ceiling value of $6,330.10 under a firm fixed-price contract type. The award was made on August 7, 2025, with an ultimate completion date of August 8, 2025, and carries no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate office location in the same...
- The Defense Logistics Agency awarded a delivery order valued at $1,793.21 to AmerisourceBergen Drug Corp for the supply of Adderall 5 mg tablets (100-count units) with a firm fixed price and a completion deadline of August 26, 2025. This non-set-aside, competitively awarded contract represents a child delivery order executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), which carries a $999.999 billion potential value through...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FE0HEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Adderall 15 mg tablets (quantity 100s) valued at $3,934.25 under a firm fixed price contract type. This non-set-aside award was issued on September 17, 2025, with an ultimate completion date of September 18, 2025. The place of performance is located in Conshohocken, Pennsylvania, which serves as the company's corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $1 billion prime contract vehicle valued through December 2026 that provides comprehensive global pharmaceutical support for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen Drug Corp supplies a wide range of medical products including brand-name and generic medications, vaccines, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide. The company's consistent track record of successful federal medical procurement through competitive awards demonstrates its capability to fulfill critical pharmaceutical supply requirements for military and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/17/25 |